Response to MSAC consultation on HbA1c point of care testing


Date: 16 July 2016

The Protocol Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) sought comment on the draft protocol for HbA1c point of care testing for the diagnosis and management of diabetes mellitus.

The proposed medical service is for the use of in vitro diagnostic test instrument that meets defined acceptable performance criteria comparable to laboratory based testing being performed at or near the site of patient care (e.g. within GP consulting rooms) for the quantification of HbA1c (glycated haemoglobin) in human whole blood.